The drug is mainly used to treat obesity and type 2 diabetes, and has attracted much attention for its excellent weight loss and blood sugar control effects
Novo Nordisk's Wegovy and Ozempic recorded sales of Rs 12 crore and Rs 11 crore, respectively, cutting prices by more than 40% after semaglutide's patent expiry in April
Common gastrointestinal challenges can lead to fluid and electrolyte imbalances, food intolerances, malabsorption, nutrient deficiencies, weight loss and disorders of the gut brain connection
Vascular Endothelial Growth Factor (VEGF) and its receptor (vegfr) signaling in angiogenesis: A crucial target for anti- and pro-angiogenic therapies
Before procedures/anesthesia: Current multi-society guidance says most patients can continue GLP-1s, but plans should be individualized with your surgeon/anesthesiologistespecially if you have significant GI symptoms